Trading update: H1 meets expectations
In a Trading Update for the first half to 30 June 2023, Mpac reports that trading was in line with...
Read moreXF-73 Momentum
Destiny’s recent business update noted the continued partnering interest on XF-73 Nasal – its now...
Read moreFY23 results ahead of expectations
ECO Animal Health Group reported revenue for the year to 31 March 2023 of £85.3m (+4%YoY) and...
Read moreSlow Q3, dividend yield now over 5%
On 30 Jun 23 (end-Q3 FY23), AUM totalled £39.7bn, 1% (£0.4bn) down over the quarter (31 Mar 23:...
Read more
Strong FY23 results backed by vaping acquisitions
For the year to 31 March 23, Supreme reported revenue of £155.6m, +19%YoY (with H2 revenue...
Read moreEncouraging AGM update & Investor Day insights
The AGM update was encouraging and indicated that ‘green shoots’ continued to emerge, with momentum...
Read moreFY23 profits in line, pipeline strong
MW has reported a y-o-y revenue increase of 3% for FY23 ending on 31 May 23 (FY22: £108.2m). While...
Read moreDiscussions underway to unlock value
The investment case pivots on the progress of strategic options under consideration for the two...
Read moreAGM and recent financing
Kinarus’ Therapeutics AG held its AGM on June 28th. Shareholders approved all proposals,...
Read more
Records broken and encouraging trends
The Group has delivered record revenues and EBITDA in H1 to March 2023. The rising proportion of...
Read moreRegister to be first
Get research on the companies that interest you straight to your inbox
